Economic Burden of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in Europe, from the Caregivers Perspective

Author(s)

Solanke O1, Martel MJ2, Buesch K3
1Xcenda, London, LON, UK, 2Xcenda, LLC, Palm Harbor, FL, USA, 3PTC Therapeutics Switzerland GmbH, Steinhausen, Switzerland

OBJECTIVES: AADC deficiency, a rare neurometabolic disorder associated with significant developmental delay and functional impairments, requires intensive highly specialized lifelong care. This study aimed to estimate the economic burden and indirect costs of AADC deficiency from the caregiver’s perspective.

METHODS: An Excel model was developed to assess weekly and annual costs associated with caregiving in four European countries (Belgium, Italy, Spain, and UK). Time spent providing care, paid and unpaid support, and impact on employment were obtained via questionnaire, and country-specific associated costs, estimated using public national sources.

RESULTS: Estimated number of individuals with AADC deficiency ranged from 2 (Spain) to 16 (Italy). Primary caregivers reported spending an average of 90 hours (range: 56-140) weekly on practical and emotional care, plus 15 hours (range: 7-33) on administrative tasks. Annually, 9,360 - 74,880 hours on average were spent on practical and emotional care, representing an estimated total of €111,852 to €1.6 million. Caregivers further spent 30 to 240 hours weekly on average (1,560 – 12,480 hours/year) on administrative tasks, representing an estimated total of €358 – €5,112 per week (€18,642 – €265,824 annually). 55% of caregivers received 35 to 277 hours weekly in paid and unpaid support (1,798 - 14,380 hours/year), translating into an estimated total of € 493 - €5,866 weekly (€25,625 to €305,006 annually). For countries studied, the resulting total cost of caregiving ranged from €5,206 - €24,018 weekly (€156,119 to €2.2 million per annum). Further, the loss of income owing to 75% of primary caregivers leaving work or reducing working hours was estimated to €16,658 - €227,429 per year.

CONCLUSIONS: Findings show how the significant time and support needed to care for individuals with AADC deficiency and primary caregivers’ reduced participation in the workforce translate into substantial costs to society, thereby providing a further aspect of the economic burden associated with AADC deficiency.

Conference/Value in Health Info

2021-11, ISPOR Europe 2021, Copenhagen, Denmark

Value in Health, Volume 24, Issue 12, S2 (December 2021)

Code

POSA360

Topic

Economic Evaluation

Topic Subcategory

Work & Home Productivity - Indirect Costs

Disease

Rare and Orphan Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×